Navigation Links
Neurocrine Advances VMAT2 Inhibitor Program
Date:12/21/2009

h respect to the Company's VMAT2 program include, but are not limited to; risk that NBI-98854 will not proceed to later stage clinical trials and risk that the Company's clinical trials will fail to demonstrate that NBI-98854 is safe and effective. With respect to its pipeline overall, the Company faces risk that it will be unable to raise additional funding required to complete development of all of its product candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate partners for development, commercial manufacturing and marketing and sales activities for the Company's partnered programs; uncertainties relating to patent protection and intellectual property rights of third parties; risks and uncertainties relating to competitive products and technological changes that may limit demand for the Company's products; and the other risks described in the Company's report on Form 10-K for the year ended December 31, 2008 and reports of 10-Q for the quarter ended September 30, 2009. Neurocrine undertakes no obligation to update the statements contained in this press release after the date hereof.

SOURCE Neurocrine Biosciences, Inc.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Neurocrine Biosciences Reports First Quarter 2008 Results
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
5. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
6. Neurocrine Biosciences Presents Elagolix Data
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
8. Neurocrine Biosciences Reports Third Quarter 2009 Results
9. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... -- Thoratec Corporation (NASDAQ: THOR ), a world ... and restore failing hearts, said today it will participate ... Conference on Tuesday, June 9. D. ... provide an update on the company, beginning at 2:00 ... The presentation will be available through the ...
(Date:5/26/2015)... , England and PITTSBURGH , May 26, ... leading global pharmaceutical company, today announced that Mylan CEO ... Bernstein Strategic Decisions Conference, Friday, May 29, 2015 at ... access a live webcast of the presentation via the ... . An archived version will also be available following ...
(Date:5/26/2015)...  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ) ("the ... therapeutics that address unmet medical needs in women,s ... will present at the Marcum MicroCap Conference ... 4:00 PM EDTLocation: , The Grand Hyatt, New ... under  ,Investor, or  click here The ...
Breaking Medicine Technology:Thoratec Presentation At Goldman Sachs Healthcare Conference To Be Webcast 2Juniper Pharmaceuticals to Present at Investor Conference on May 28, 2015 2
... Havas Drive, the innovation unit of Havas Worldwide Health, ... persons with disabilities and those undergoing rehabilitative therapies. ... Web accessibility with a list of publications that have ... Management program and the Sandra Day O,Connor College of ...
... N.J., March 28, 2011 Roche announced today that ... Vice President, Translational Medicine – Virology in Pharmaceutical Research ... will report to Jacques Banchereau, Ph.D., Discovery and Translational ... Scientific Officer at Nutley, and be responsible for driving ...
Cached Medicine Technology:Havas Drive Launches New Services Aimed at Improving Digital and Web Accessibility 2Janet Hammond Joins Roche as Vice President, Translational Medicine - Virology 2Janet Hammond Joins Roche as Vice President, Translational Medicine - Virology 3
(Date:5/26/2015)... Platte, LA (PRWEB) May 26, 2015 ... readers along with her as she writes an unforgettable ... difficult challenges in her life. The first black student ... was harassed and beaten by some students, treated harshly ... white woman. A motivating personal phone conversation with Dr. ...
(Date:5/26/2015)... The federal court overseeing more than ... of individuals who were allegedly injured by the medication ... Day. According to an Order issued in the U.S. ... topics to be addressed include Xarelto adverse events, clinical ... test based testing with Xarelto, and Xarelto pharmacology. All ...
(Date:5/26/2015)... NM (PRWEB) May 26, 2015 ... providing New Mexico patients with MRI, Ultrasound, and ... by the American College of Radiology. The center ... CT services. , In order to be ... a variety of qualifications including personnel qualifications, adequacy ...
(Date:5/26/2015)... 2015 Surging to over 674,923 of ... leading online health and wellness sites, Consumer Health Digest ... community. It has proven to be a reliable ... watch videos, ask questions and interact with the online ... official Consumer Health Digest YouTube Channel has offered a ...
(Date:5/26/2015)... 3,000 senior industry executives are expected ... the future of the connected car. A very special ... that can read a driver’s brain waves. Visitors to ... simulator by mind alone just by gripping the steering ... “We are working on cognitive load, altering music based ...
Breaking Medicine News(10 mins):Health News:Grace Sibley Releases Second Book, God's Unstoppable Favor 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 3Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 4Health News:Consumer Health Digest Official YouTube Channel: A Reliable Source of Health Information 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 3
... reduce up to 70 percent of spina bifida cases, according ... which the neural tube (an embryonic form of the brain ... condition that involves lifelong medical management. It is also one ... show that folic acid supplementation around the time of conception ...
... of drugs prescribed to children with depression may have ... a new study. Researchers say they found a reduction ... more commonly known as Prozac. Fluoxetine is the only ... and adolescents. ,Other preliminary studies show the use ...
... more use to humans than just for honey find researchers ... of bee venom was given to rats with advanced rheumatoid ... swelling on affected paws. ,Researchers then examined the effects ... obtained from human patients. The venom blocked the expression of ...
... now say they’ve found one drug that may successfully treat ... 22 patients with breast, prostate, lung, ovarian, colon and pancreatic ... by more than 50 percent. Specialists say , it turns ... stop it from growing, and so there’s much less side ...
... shows that gaining 15 pounds or more over several years puts ... are obese but maintain a stable weight . ,Researchers ... years. Most participants gained 15 pounds or more during the study, ... problems such as heart disease, stroke and diabetes. But only 4 ...
... infection can now be virtually eliminated by a one-time ... a recent study . Researchers studied a community in ... At the beginning of the study, nearly 10 percent ... causes repeated symptoms that can eventually lead to scarring ...
Cached Medicine News:
... transmitted through sorted fiberglass bundles ... transmit it to a user's ... designed for rough, industrial handling ... low cost if they should ...
The original Zeppelin High-Speed Motordrill System has been developed to rapidly cut bone, plastic and metal with utmost precision. 120-150 psi - 90.000 rpm - 90g - autoclavable at <134 C....
... is a high speed pneumatic ... dissection of bone, biometals, bioplastics ... not only provides speed 80,000 ... the control and precision that ...
Legend Gold is the most powerful of the new motors. It runs at an impressive 76,000 rpm at 120 psi/8 bar. It is also smaller than the Midas Rex Classic motor, with an enhanced ergonomic design....
Medicine Products: